Italy will receive about 40,000 doses of Merck COVID-19 antiviral next week, which will be added to the nearly 12,000 already distributed to hospitals, the coronavirus commissioner said on Sunday, according to Reuters.
“They are intended for clinical cases that are at risk of a serious outcome of the disease,” Commissioner Francesco Figliuolo said on a TV show on the Italian channel RAI 3.
Italy will also receive 200,000 Pfizer COVID-19s in February, Figliuolo said, adding that Rome could buy an additional 400,000 doses of Pfizer Paxlovid.
The office of the special commissioner for coronavirus said in November that it had received an order from the Ministry of Health to buy 50,000 packages of Merck pill and another 50,000 of Pfizer pill.
While vaccines are the main weapons against COVID-19 for governments, there is hope that the Merck and Pfizer experimental pills could change the data in reducing the chances of death or hospitalization for those at greater risk of serious illness.
.
Source From: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
